IMMY买入原因:今天IMMY发的干眼症药物为Restasis的仿制药,RESTASIS 2016年第三季度全球销售额为371.6million, 第四季度全球销售额393.1 million占干眼症市场的80%,现有竞争对手仅有Shire’s idra,占20%的市场。IMMY的仿制药由于是走低价路线,有可...查看全文
TLS美股研究2017-04-09 21:31
回复@panderson: $IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 我们看看。我刚打赏了这条评论 ¥2.88,也推荐给你。//@panderson:回复@TLS美股研究:IMMY值得关注,眼科市场天花板逐渐打开,公司高管参与增发,市值迷你,会是小黑马吗 查看全文
$Imprimis Pharmaceuticals, Inc.(IMMY)$ 8-K - Current report Filed: 2017-08-28 AccNo: 0001493152-17-009916 Size: 7 MBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$Imprimis Pharmaceuticals, Inc.(IMMY)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2017-08-25 AccNo: 0001493152-17-009907 Size: 248 KB 网页链接
$Imprimis Pharmaceuticals, Inc.(IMMY)$ 8-K - Current report Filed: 2017-08-25 AccNo: 0001493152-17-009906 Size: 39 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersIte...
$Imprimis Pharmaceuticals, Inc.(IMMY)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2017-08-25 AccNo: 0001493152-17-009901 Size: 563 KB 网页链接
$Imprimis Pharmaceuticals, Inc.(IMMY)$ 8-K - Current report Filed: 2017-08-25 AccNo: 0001493152-17-009906 Size: 39 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersIte...
$Imprimis Pharmaceuticals, Inc.(IMMY)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2017-08-25 AccNo: 0001493152-17-009901 Size: 563 KB 网页链接
$Imprimis Pharmaceuticals, Inc.(IMMY)$ 8-K - Current report Filed: 2017-08-10 AccNo: 0001493152-17-008882 Size: 134 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Imprimis Pharmaceuticals, Inc.(IMMY)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-08-10 AccNo: 0001493152-17-008881 Size: 5 MB 网页链接
$Imprimis Pharmaceuticals, Inc.(IMMY)$ 美东时间 2017-08-10 盘后 披露财报,预期EPS n/a 网页链接
$Imprimis Pharmaceuticals, Inc.(IMMY)$ 8-K - Current report: i Filed: 2017-07-20 AccNo: 0001493152-17-008000 Size: 597 KBItem 1.01: Entry into a Material Definitive AgreementItem 1.02: Termination of a Material Definitive AgreementItem 2.01: Completion of Acquisition or Dispo...